ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2695

Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis

Youngkyun Kim1, Kijun Lee2, Hae-Rim Kim3, Sang Heon Lee4, Ji Hyeon Ju5 and HO-YOUN KIM6, 11Convergent Research Consortium for Immunologic Disease, The Catholic University of Korea, Seoul, South Korea, 2The Catholic University of Korea, Seoul, South Korea, 3Konkuk University Medical Center, Seoul, South Korea, 4Konkuk University Hospital, Seoul, South Korea, 5Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 6Konkuk university hospital, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Diagnostic Tests, Early Rheumatoid Arthritis, T cells and cytokines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The purpose of this study is to explore new biomarkers for early diagnosis of rheumatoid arthritis (RA). For better discrimination power, we especially investigated the samples of early RA (eRA) patients whose onset of RA were less than 1 year.

Methods: We examined the serum cytokines and the gene expression profiles of peripheral mononuclear cells from early rheumatoid arthritis (eRA). eRA samples were compared with advanced RA (aRA, disease duration more than 1 year) and osteoarthritis. Serum obtained from 44 patients with eRA were evaluated for cytokine panels, including IFN-r, IL-12, IL-2, IL-4, IL-10, IL-17 and IL-6. Gene expression profiles of eRA (n=11), using microarray analysis, were compared with OA (n=8) and aRA (n=7). Biomarker candidates were positively selected by pathway analysis using NCBI database about Th17 cell differentiation genes.

Results: Mean age of eRA and aRA were 51.9 and 58.1 respectively. CRP level was higher in aRA than eRA (3.27 vs 1.19 mg/dL, P<0.02). Th17 cell-related cytokines like IL-6 and IL-17 were prominent than other cytokines in eRA patients. IL-17 concentration was statistically higher in eRA than aRA. Positive percentage of IL-6 was more than 50% in eRA patients. IL-6 were well correlated with ESR (r=0.3, P=0.006) and CRP (r=0.6, P<0.001). Interestingly, IL-17 levels were correlated with disease activity DAS28 (r=0.45, P=0.003). 255 genes were upregulated in eRA (|F.C|>1.3, P<0.05). 10 genes were selected from 255 genes by association analysis with Th17 differentiation as followings, TMEM140 (transmembrane protein 140), NUAK2 (NUAK family, SNF1-like kinase 2), SULT1A3 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3), HIST1H4H (histone cluster 1, H4h), NAPSB (napsin B aspartic peptidase pseudogene), FEN1 (flap structure-specific endonuclease 1), PROS1 (protein S alpha), RPS6KA2 (ribosomal protein S6 kinase, 90kDa, polypeptide 2), CDKN3 (cyclin-dependent kinase inhibitor 3), JAM3 (junctional adhesion molecule 3).

Conclusion: Th17-related cytokines were dominant at early stage of RA and associated with disease activity. Th17-related candidate genes could give a new insight as biomarkers for early diagnosis and therapeutic target for eRA.


Disclosure: Y. Kim, None; K. Lee, None; H. R. Kim, None; S. H. Lee, None; J. H. Ju, None; H. Y. KIM, None.

To cite this abstract in AMA style:

Kim Y, Lee K, Kim HR, Lee SH, Ju JH, KIM HY. Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/th17-cell-related-cytokines-and-microarray-expression-profiles-in-patients-with-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/th17-cell-related-cytokines-and-microarray-expression-profiles-in-patients-with-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology